Natco Pharma up 7%, receives EIR from USFDA for Chennai plant

The company has received a successful establishment inspection report (EIR) from the US food and drug administration (FDA) for its chemical division, Chennai, India.

August 25, 2016 / 10:14 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Moneycontrol BureauShares of Natco Pharma gained 7.4 percent intraday Thursday on receipt of establishment inspection report for its Chennai plant.The company has received a successful establishment inspection report (EIR) from the US food and drug administration (FDA) for its chemical division, Chennai, India.The inspection has been conducted, during the period February 8 - February 12, 2016.Earlier in this month, it had received EIR from the USFDA for its drug manufacturing facility in Kothur Village.At 10:02 hrs Natco Pharma was quoting at Rs 694.15, up Rs 38.95, or 5.94 percent. It has touched a 52-week high of Rs 703.95 on the BSE. Posted by Rakesh Patil

first published: Aug 25, 2016 10:14 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

Al Edge Newsletter On Saturdays

Find the best of Al News in one place, specially curated for you every weekend.
MC Tech 3 Newsletter Daily-Weekdays

Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347